Notch signaling promotes survival and recurrence of dormant mammary tumor cells following HER2/neu targeted therapy

被引：0
|
作者：
Abravanel, Daniel L. [1 ]
Collins, Meredith A. [1 ]
Belka, George K. [1 ]
Pan, Tien-chi [1 ]
Pant, Dhruv K. [1 ]
Sterner, Christopher J. [1 ]
Chodosh, Lewis A. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2894
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2894
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Expression of Her2/neu in locally advanced bladder cancer:: Implication for a molecular targeted therapy
    Wülfing, C
    von Struensee, D
    Bierer, S
    Bögemann, M
    Hertle, L
    Eltze, E
    [J]. AKTUELLE UROLOGIE, 2005, 36 (05) : 423 - 429
  • [22] EXPRESSION OF HER2/NEU ON RESECTABLE COLORECTAL ADENOCARCINOMA CELLS DOES NOT CORRELATE WITH SURVIVAL
    Kruszewski, W.
    Rzepko, R.
    Zielinski, J.
    Wojtacki, J.
    Ciesielski, M.
    Szefel, J.
    Jasinski, W.
    Szajewski, M.
    Kawecki, K.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 31 - 31
  • [23] Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion
    Huang, Tzu-Hsuan
    Wu, Fangting
    Loeb, Gabriel B.
    Hsu, Ruby
    Heidersbach, Amy
    Brincat, Allison
    Horiuchi, Dai
    Lebbink, Robert J.
    Mo, Yin-Yuan
    Goga, Andrei
    McManus, Michael T.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (27) : 18515 - 18524
  • [24] Interferon-gamma potentiates the targeted phenotypic reversion of erbb2/her2/neu transformed human tumor cells
    Runkle, Edwin Aaron
    Young, Peter
    Nagai, Yasuhiro
    Tsuchiya, Hiromichi
    Zhang, Hongtao
    Greene, Mark I.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [25] Accelerated Mammary Tumor Onset in a HER2/Neu Mouse Model Exposed to DDT Metabolites Locally Delivered to the Mammary Gland
    Johnson, Nakpangi A.
    Ho, Arline
    Cline, J. Mark
    Hughes, Claude L.
    Foster, Warren G.
    Davis, Vicki L.
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2012, 120 (08) : 1170 - 1176
  • [26] Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage
    Urbanelli, L
    Ronchini, C
    Fontana, L
    Menard, S
    Orlandi, R
    Monaci, P
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 313 (05) : 965 - 976
  • [27] HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy
    Rottmann, Douglas
    Snir, Olivia L.
    Wu, Xinyu
    Wong, Serena
    Hui, Pei
    Santin, Alessandro D.
    Buza, Natalia
    [J]. MODERN PATHOLOGY, 2020, 33 (01) : 118 - 127
  • [28] Deletion of STAT5 prevents HER2/Neu/ErbB2-induced mammary tumor development
    Yamaji, D.
    Robinson, G. W.
    Muller, W. J.
    Hennighausen, L.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 218S - 218S
  • [29] Human breast cancer tumor models:: Molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy
    Gee, Michael S.
    Upadhyay, Rabi
    Bergquist, Henry
    Alencar, Herlen
    Reynolds, Fred
    Maricevich, Marco
    Weissleder, Ralph
    Josephson, Lee
    Mahmood, Umar
    [J]. RADIOLOGY, 2008, 248 (03) : 925 - 935
  • [30] Enhancing HER2/neu Specific T-cell Therapy by Targeting the Tumor Endothelium
    Vy Phan Lai
    Buckanovich, Ronald J.
    Gad, Ekram
    Bigdeli, Laleh
    Disis, Mary L.
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182
12345